Staar Surgical (STAA) Liabilities and Shareholders Equity (2010 - 2026)

Staar Surgical has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $451.1 million in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 1.37% year-over-year to $451.1 million; the trailing twelve-month figure through Apr 2026 stood at $1.8 billion (down 10.92% YoY), and the FY2026 full-year result was $451.7 million, down 11.35% from the prior year.
• Liabilities and Shareholders Equity for Q2 2026 stood at $451.1 million, roughly flat from $451.7 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $537.6 million in Q3 2024, with the low at $351.2 million in Q2 2022.
• Historically, Liabilities and Shareholders Equity has averaged $451.0 million across 5 years, with a median of $451.7 million in 2026.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 32.12% — and 2025, when it dropped 15.11%.
• Staar Surgical's Liabilities and Shareholders Equity stood at $418.8 million in 2022, then advanced by 16.68% to $488.7 million in 2023, then increased by 4.26% to $509.5 million in 2024, then retreated by 10.43% to $456.4 million in 2025, then slipped by 1.15% to $451.1 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $451.1 million (Q2 2026), $451.7 million (Q1 2026), and $456.4 million (Q3 2025), per Business Quant data.